<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2216-0973</journal-id>
<journal-title><![CDATA[Revista Cuidarte]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Cuid]]></abbrev-journal-title>
<issn>2216-0973</issn>
<publisher>
<publisher-name><![CDATA[Programa de Enfermería, Facultad de Ciencias de la Salud, Universidad de Santander UDES]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2216-09732017000101519</article-id>
<article-id pub-id-type="doi">10.15649/cuidarte.v8i1.371</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[FACTORES DE RIESGO PARA DISFUNCIÓN SISTÓLICA VENTRICULAR IZQUIERDA EN ADULTOS DE UN PROGRAMA DE SALUD GLOBAL]]></article-title>
<article-title xml:lang="pt"><![CDATA[FATORES DE RISCO PARA DISFUNÇÃO SISTÓLICA VENTRICULAR ESQUERDA EM ADULTOS DE UM PROGRAMA DE SAÚDE GLOBAL]]></article-title>
<article-title xml:lang="en"><![CDATA[RISK FACTORS FOR LEFT VENTRICULAR SYSTOLIC DYSFUNCTION IN ADULTS FROM A GLOBAL HEALTH PROGRAM]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Giraldo-Castrillón]]></surname>
<given-names><![CDATA[Yessica María]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Muñoz]]></surname>
<given-names><![CDATA[Fabián]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Navarro-Lechuga]]></surname>
<given-names><![CDATA[Edgar]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Segura-Cardona]]></surname>
<given-names><![CDATA[Ángela María]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad CES  ]]></institution>
<addr-line><![CDATA[Medellín ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad CES  ]]></institution>
<addr-line><![CDATA[Medellín ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad del Norte  ]]></institution>
<addr-line><![CDATA[Barranquilla ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Universidad CES  ]]></institution>
<addr-line><![CDATA[Medellín ]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2017</year>
</pub-date>
<volume>8</volume>
<numero>1</numero>
<fpage>1519</fpage>
<lpage>1528</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S2216-09732017000101519&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S2216-09732017000101519&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S2216-09732017000101519&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción: La falla cardiaca, es un síndrome clínico habitualmente progresivo que con frecuencia comienza como disfunción sistólica ventricular izquierda y culmina con manifestaciones clínicas diversas de fallo de bomba y bajo gasto cardiaco hasta la muerte. Objetivo: Caracterizar los factores de riesgo que están asociados al desarrollo de disfunción sistólica ventricular izquierda y falla cardiaca secundaria como parte del espectro del síndrome de falla cardiaca en la población de Barranquilla-Colombia.  Materiales y Métodos:  Se realizó un estudio descriptivo de corte transversal con fuente secundaria de un estudio de salud global en la ciudad de Barranquilla-Colombia, en el que se hizo análisis univariado y bivariado para describir factores de riesgo asociados a la disfunción sistólica ventricular izquierda.  Resultados:  Se obtuvieron las prevalencias de cuatro factores de riesgo asociados al desarrollo de disfunción sistólica ventricular izquierda: hipertensión arterial 29.7%, obesidad 26.5%, hiperglucemia 4.6%, hipercolesterolemia 8.2% en pacientes mayores de 40 años los cuales tienen mayor riesgo.  Discusión:  Este estudio buscó llamar la atención sobre la disfunción sistólica ventricular izquierda, como una condición de descripción relativamente reciente y de potencial impacto en la salud de las poblaciones y los recursos de los sistemas de salud.  Conclusiones:  La prevalencia de los factores de riesgo para este estado pre-clínico podría llegar a ser alta y estos pacientes ameritarían, según recomendación de cierta evidencia, tamización para disfunción sistólica ventricular izquierda, así como estudios adicionales son requeridos.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[RESUMO  Introdução:  A insuficiência cardíaca é uma síndrome clínica habitualmente progressiva que, muitas vezes começa como disfunção sistólica ventricular esquerda e termina com diversas manifestações clínicas de falha da bomba e baixo débito cardíaco até a morte. Objetivo: Caracterizar os fatores de risco que estão associados ao desenvolvimento da disfunção sistólica ventricular esquerda e insuficiência cardíaca secundária como parte do espectro da síndrome de insuficiência cardíaca na população de Barranquilla-Colômbia.  Materiais e Métodos:  Realizou-se um estudo descritivo de corte transversal, fonte secundária de um estudo da saúde global na cidade de Barranquilla-Colômbia, e foi realizada uma análise univariada e bivariada para descrever os fatores de risco associados à disfunção sistólica ventricular esquerda.  Resultados:  Foram obtidas as prevalências de quatro fatores de risco associados ao desenvolvimento da disfunção sistólica ventricular esquerda: hipertensão arterial 29.7%, obesidade 26.5%, hiperglicemia 4.6%, hipercolesterolemia 8.2%, nos pacientes acima de 40 anos, os quais têm mais risco.  Discussão:  Este estudo buscou chamar a atenção sobre a disfunção sistólica ventricular esquerda, como uma condição de descrição relativamente recente e de impacto potencial na saúde das populações e os recursos dos sistemas de saúde.  Conclusões:  A prevalência de fatores de risco para este estado pré-clínico poderia tornar-se alta, e estes doentes precisariam segundo a recomendação de algumas evidências, rastreio para disfunção sistólica ventricular esquerda, bem como necessidade de estudos adicionais.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction: Heart failure is a habitually progressive clinical syndrome that frequently starts as left ventricular systolic dysfunction and culminates with diverse clinical manifestations of pump failure and low cardiac output and even death. Objective: The research sought to characterize the risk factors associated to the development of left ventricular systolic dysfunction and secondary heart failure as part of the spectrum of the heart failure syndrome in the population of Barranquilla-Colombia.  Materials and Methods:  A cross-sectional descriptive study was conducted with secondary source from a global health study in the city of Barranquilla-Colombia, which performed univariate and bivariate analysis to describe risk factors associated to left ventricular systolic dysfunction.  Results:  The study obtained the prevalence of four risk factors associated to the development de left ventricular systolic dysfunction: arterial hypertension (29.7%), obesity (26.5%), hyperglycemia (4.6%), and hypercholesterolemia (8.2%) in patients over 40 years of age, who are at higher risk.  Discussion:  This study sought to draw attention on the left ventricular systolic dysfunction, as a condition of relatively recent description and of potential impact on the health of populations and the resources of health systems.  Conclusions:  The prevalence of risk factors for this pre-clinical state could be high and these patients would merit, per recommendation of certain evidence, screening for left ventricular systolic dysfunction, as well as additional studies are required.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Factores de Riesgo]]></kwd>
<kwd lng="es"><![CDATA[Síndrome]]></kwd>
<kwd lng="es"><![CDATA[Disfunción Ventricular Izquierda]]></kwd>
<kwd lng="pt"><![CDATA[Fatores de Risco]]></kwd>
<kwd lng="pt"><![CDATA[Síndrome]]></kwd>
<kwd lng="pt"><![CDATA[Disfunção Ventricular Esquerda]]></kwd>
<kwd lng="en"><![CDATA[Risk Factors]]></kwd>
<kwd lng="en"><![CDATA[Syndrome]]></kwd>
<kwd lng="en"><![CDATA[Left Ventricular Dysfunction]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lozano]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Naghavi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Foreman]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Lim]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Shibuya]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Aboyans]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<source><![CDATA[Lancet]]></source>
<year>2013</year>
<volume>380</volume>
<numero>9859</numero>
<issue>9859</issue>
<page-range>2095-128</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="">
<collab>World Health Organization</collab>
<source><![CDATA[Global status report on noncommunicable diseases 2014]]></source>
<year>2014</year>
</nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Velásquez]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Duque]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Uribe]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Franco]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<source><![CDATA[Guías de manejo en enfermedades cardíacas y vasculares. Estado actual, 2012]]></source>
<year>2012</year>
<page-range>720</page-range><publisher-loc><![CDATA[Bogotá ]]></publisher-loc>
<publisher-name><![CDATA[Distribuna]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Disfunción sistólica ventricular izquierda asintomática]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tacchi]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Insuf Card]]></source>
<year>2007</year>
<volume>2</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>32-7</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yancy]]></surname>
<given-names><![CDATA[CW]]></given-names>
</name>
<name>
<surname><![CDATA[Jessup]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bozkurt]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Butler]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Casey Jr]]></surname>
<given-names><![CDATA[DE]]></given-names>
</name>
<name>
<surname><![CDATA[Drazner]]></surname>
<given-names><![CDATA[MH]]></given-names>
</name>
</person-group>
<source><![CDATA[J Am Coll Cardiol]]></source>
<year>2013</year>
<volume>62</volume>
<numero>16</numero>
<issue>16</issue>
<page-range>47-239</page-range></nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Myocardial strain to detect subtle left ventricular systolic dysfunction]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tops]]></surname>
<given-names><![CDATA[LF]]></given-names>
</name>
<name>
<surname><![CDATA[Delgado]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Marsan]]></surname>
<given-names><![CDATA[NA]]></given-names>
</name>
<name>
<surname><![CDATA[Bax]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
</person-group>
<source><![CDATA[Eur J Heart Fail]]></source>
<year>2016</year>
</nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The epidemiology of "asymptomatic" left ventricular systolic dysfunction: implications for screening]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[TJ]]></given-names>
</name>
<name>
<surname><![CDATA[Levy]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Benjamin]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Vasan]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
</person-group>
<source><![CDATA[Ann Intern Med]]></source>
<year>2003</year>
<volume>138</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>907-16</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[McMurray]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Adamopolous]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Anker]]></surname>
<given-names><![CDATA[SD]]></given-names>
</name>
<name>
<surname><![CDATA[Auricchio]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Böhm]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Dickstein]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<source><![CDATA[Eur Heart J]]></source>
<year>2012</year>
<volume>33</volume>
<numero>14</numero>
<issue>14</issue>
<page-range>1787-847</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions]]></article-title>
<collab>The SOLVD investigators</collab>
<source><![CDATA[N Engl J Med]]></source>
<year>1992</year>
<volume>327</volume>
<page-range>685-91</page-range></nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pfeffer]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Braunwald]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Moyé]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
<name>
<surname><![CDATA[Basta]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Brown Jr]]></surname>
<given-names><![CDATA[EJ]]></given-names>
</name>
<name>
<surname><![CDATA[Cuddy]]></surname>
<given-names><![CDATA[TE]]></given-names>
</name>
</person-group>
<source><![CDATA[N Engl J Med]]></source>
<year>1992</year>
<volume>327</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>669-77</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Goldberg]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Jessup]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Circulation]]></source>
<year>2006</year>
<volume>113</volume>
<numero>24</numero>
<issue>24</issue>
<page-range>2851-60</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[International Physical Activity Questionnaire. An adequate instrument in population physical activity monitoring]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mantilla-Toloza]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
<name>
<surname><![CDATA[Gómez-Conesa]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Iberoam Fisiote Kinesol]]></source>
<year>2007</year>
<volume>10</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>48-52</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[International physical activity questionnaire: 12-country reliability and validity]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Craig]]></surname>
<given-names><![CDATA[CL]]></given-names>
</name>
<name>
<surname><![CDATA[Marshall]]></surname>
<given-names><![CDATA[AL]]></given-names>
</name>
<name>
<surname><![CDATA[Sjöström]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bauman]]></surname>
<given-names><![CDATA[AE]]></given-names>
</name>
<name>
<surname><![CDATA[Booth]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[Ainsworth]]></surname>
<given-names><![CDATA[BE]]></given-names>
</name>
</person-group>
<source><![CDATA[Med Sci Sports Exerc]]></source>
<year>2003</year>
<volume>35</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>1381-95</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The 2012 Canadian Cardiovascular Society heart failure management guidelines update: focus on acute and chronic heart failure]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[McKelvie]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
<name>
<surname><![CDATA[Moe]]></surname>
<given-names><![CDATA[GW]]></given-names>
</name>
<name>
<surname><![CDATA[Ezekowitz]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Heckman]]></surname>
<given-names><![CDATA[GA]]></given-names>
</name>
<name>
<surname><![CDATA[Costigan]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Ducharme]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Can J Cardiol]]></source>
<year>2013</year>
<volume>29</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>168-81</page-range></nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Prognostic Implications of sub clinical left ventricular dilation and systolic dysfunction in men free of overt cardiovascular disease (the Framingham Heart Study)]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lauer]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Evans]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Levy]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<source><![CDATA[Am J Cardiol]]></source>
<year>1992</year>
<volume>70</volume>
<numero>13</numero>
<issue>13</issue>
<page-range>1180-4</page-range></nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Péptidos natriuréticos en insuficiencia cardiaca]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Almenar-Bonet]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez-Dols]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Esp Cardiol Supl]]></source>
<year>2006</year>
<volume>6</volume>
<numero>F</numero>
<issue>F</issue>
<page-range>15-26</page-range></nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Coronary artery disease in young adults]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Klein]]></surname>
<given-names><![CDATA[LW]]></given-names>
</name>
<name>
<surname><![CDATA[Nathan]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<source><![CDATA[J Am Coll Cardiol]]></source>
<year>2003</year>
<volume>41</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>529-31</page-range></nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Valor pronóstico de la disfunción ventricular izquierda inducida por el ejercicio en pacientes hipertensos sin enfermedad arterial coronaria]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Prada-Delgado]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Barge-Caballero]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Peteiro]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Bouzas-Mosquera]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Estévez-Loureiro]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Barge-Caballero]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Esp Cardiol]]></source>
<year>2015</year>
<volume>68</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>107-14</page-range></nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[van Riet]]></surname>
<given-names><![CDATA[EE]]></given-names>
</name>
<name>
<surname><![CDATA[Hoes]]></surname>
<given-names><![CDATA[AW]]></given-names>
</name>
<name>
<surname><![CDATA[Wagenaar]]></surname>
<given-names><![CDATA[KP]]></given-names>
</name>
<name>
<surname><![CDATA[Limburg]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Landman]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Rutten]]></surname>
<given-names><![CDATA[FH]]></given-names>
</name>
</person-group>
<source><![CDATA[Eur J Heart Fail]]></source>
<year>2016</year>
<volume>18</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>242-52</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
